Team:SupBiotech-Paris/Bibliographie
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
Line 31: | Line 31: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Thérapie genique | |height=40px|Thérapie genique | ||
|[1] | |[1] | ||
Line 45: | Line 45: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vectorisation | |height=40px|Vectorisation | ||
|[1] | |[1] | ||
Line 59: | Line 59: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vectorisation | |height=40px|Vectorisation | ||
|[3] | |[3] | ||
Line 73: | Line 73: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vectorisation | |height=40px|Vectorisation | ||
|[5] | |[5] | ||
Line 87: | Line 87: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vectorisation | |height=40px|Vectorisation | ||
|[7] | |[7] | ||
Line 101: | Line 101: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vectorisation | |height=40px|Vectorisation | ||
|[9] | |[9] | ||
Line 115: | Line 115: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vectorisation | |height=40px|Vectorisation | ||
|[11] | |[11] | ||
Line 129: | Line 129: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vectorisation | |height=40px|Vectorisation | ||
|[13] | |[13] | ||
Line 143: | Line 143: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vectorisation | |height=40px|Vectorisation | ||
|[15] | |[15] | ||
Line 157: | Line 157: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vecteur Tissulaire | |height=40px|Vecteur Tissulaire | ||
|[2] | |[2] | ||
Line 171: | Line 171: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vecteur Tissulaire | |height=40px|Vecteur Tissulaire | ||
|[4] | |[4] | ||
Line 185: | Line 185: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vecteur Tissulaire | |height=40px|Vecteur Tissulaire | ||
|[6] | |[6] | ||
Line 199: | Line 199: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vecteur Cellulaire | |height=40px|Vecteur Cellulaire | ||
|[1] | |[1] | ||
Line 213: | Line 213: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vecteur Cellulaire | |height=40px|Vecteur Cellulaire | ||
|[3] | |[3] | ||
Line 227: | Line 227: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vecteur Cellulaire | |height=40px|Vecteur Cellulaire | ||
|[5] | |[5] | ||
Line 241: | Line 241: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vecteur Cellulaire | |height=40px|Vecteur Cellulaire | ||
|[7] | |[7] | ||
Line 255: | Line 255: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Vecteur Cellulaire | |height=40px|Vecteur Cellulaire | ||
|[9] | |[9] | ||
Line 269: | Line 269: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Plasmide thérapeutique | |height=40px|Plasmide thérapeutique | ||
|[2] | |[2] | ||
Line 283: | Line 283: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Plasmide thérapeutique | |height=40px|Plasmide thérapeutique | ||
|[4] | |[4] | ||
Line 297: | Line 297: | ||
| | | | ||
- | |- style="background: | + | |- style="background: #C0C0C0; text-align: center;" |
|height=40px|Plasmide thérapeutique | |height=40px|Plasmide thérapeutique | ||
|[6] | |[6] | ||
Line 307: | Line 307: | ||
|height=40px|Plasmide thérapeutique | |height=40px|Plasmide thérapeutique | ||
|[7] | |[7] | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |||
+ | |- style="background: #C0C0C0; text-align: center;" | ||
+ | |height=40px| | ||
+ | |[] | ||
| | | | ||
| | | |
Revision as of 10:32, 19 October 2009
Chapitre | Ref. | Auteurs | Titre | Lien |
Thérapie actuelle | [1] | |||
Thérapie actuelle | [2] | |||
Thérapie actuelle | [3] | |||
Thérapie genique | [1] | |||
Thérapie genique | [2] | |||
Vectorisation | [1] | |||
Vectorisation | [2] | |||
Vectorisation | [3] | |||
Vectorisation | [4] | |||
Vectorisation | [5] | |||
Vectorisation | [6] | |||
Vectorisation | [7] | |||
Vectorisation | [8] | |||
Vectorisation | [9] | |||
Vectorisation | [10] | |||
Vectorisation | [11] | |||
Vectorisation | [12] | |||
Vectorisation | [13] | |||
Vectorisation | [14] | |||
Vectorisation | [15] | |||
Vecteur Tissulaire | [1] | |||
Vecteur Tissulaire | [2] | |||
Vecteur Tissulaire | [3] | |||
Vecteur Tissulaire | [4] | |||
Vecteur Tissulaire | [5] | |||
Vecteur Tissulaire | [6] | |||
Vecteur Tissulaire | [7] | |||
Vecteur Cellulaire | [1] | |||
Vecteur Cellulaire | [2] | |||
Vecteur Cellulaire | [3] | |||
Vecteur Cellulaire | [4] | |||
Vecteur Cellulaire | [5] | |||
Vecteur Cellulaire | [6] | |||
Vecteur Cellulaire | [7] | |||
Vecteur Cellulaire | [8] | |||
Vecteur Cellulaire | [9] | |||
Plasmide thérapeutique | [1] | |||
Plasmide thérapeutique | [2] | |||
Plasmide thérapeutique | [3] | |||
Plasmide thérapeutique | [4] | |||
Plasmide thérapeutique | [5] | |||
Plasmide thérapeutique | [6] | |||
Plasmide thérapeutique | [7] | |||
[] |